Literature DB >> 21178963

Orthotopic aortic transplantation: a rat model to study the development of chronic vasculopathy.

Mandy Stubbendorff1, Tobias Deuse, Anna Hammel, Robert C Robbins, Hermann Reichenspurner, Sonja Schrepfer.   

Abstract

Research models of chronic rejection are essential to investigate pathobiological and pathophysiological processes during the development of transplant vasculopathy (TVP). The commonly used animal model for cardiovascular chronic rejection studies is the heterotopic heart transplant model performed in laboratory rodents. This model is used widely in experiments since Ono and Lindsey published their technique. To analyze the findings in the blood vessels, the heart has to be sectioned and all vessels have to be measured. Another method to investigate chronic rejection in cardiovascular questionings is the aortic transplant model. In the orthotopic aortic transplant model, the aorta can easily be histologically evaluated. The PVG-to-ACI model is especially useful for CAV studies, since acute vascular rejection is not a major confounding factor and Cyclosporin A (CsA) treatment does not prevent the development of CAV, similar to what we find in the clinical setting. A7-day period of CsA is required in this model to prevent acute rejection and to achieve long-term survival with the development of TVP. This model can also be used to investigate acute cellular rejection and media necrosis in xenogeneic models.

Entities:  

Mesh:

Year:  2010        PMID: 21178963      PMCID: PMC3278333          DOI: 10.3791/1989

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  5 in total

1.  Rapamycin reverses chronic graft vascular disease in a novel cardiac allograft model.

Authors:  R S Poston; M Billingham; E G Hoyt; J Pollard; R Shorthouse; R E Morris; R C Robbins
Journal:  Circulation       Date:  1999-07-06       Impact factor: 29.690

2.  Improved technique of heart transplantation in rats.

Authors:  K Ono; E S Lindsey
Journal:  J Thorac Cardiovasc Surg       Date:  1969-02       Impact factor: 5.209

3.  Chronic rejection in rat aortic allografts. An experimental model for transplant arteriosclerosis.

Authors:  A Mennander; S Tiisala; J Halttunen; S Yilmaz; T Paavonen; P Häyry
Journal:  Arterioscler Thromb       Date:  1991 May-Jun

4.  FK778 in experimental xenotransplantation: a detailed analysis of drug efficacy.

Authors:  Sonja Schrepfer; Tobias Deuse; Friedrich Koch-Nolte; Thorsten Krieger; Munif Haddad; Hansjörg Schäfer; Marc P Pelletier; Robert C Robbins; Hermann Reichenspurner
Journal:  J Heart Lung Transplant       Date:  2007-01       Impact factor: 10.247

5.  Prevention and inhibition but not reversion of chronic allograft vasculopathy by FK778.

Authors:  Tobias Deuse; Grant Hoyt; Tomoyoshi Koyanagi; Robert C Robbins; Sonja Schrepfer
Journal:  Transplantation       Date:  2008-03-27       Impact factor: 4.939

  5 in total
  1 in total

1.  Thalidomide treatment prevents chronic graft rejection after aortic transplantation in rats - an experimental study.

Authors:  Katharine K Miller; Dong Wang; Xiaomeng Hu; Xiaoqin Hua; Tobias Deuse; Evgenios Neofytou; Thomas Renne; Joachim Velden; Hermann Reichenspurner; Sonja Schrepfer; Daniel Bernstein
Journal:  Transpl Int       Date:  2017-08-14       Impact factor: 3.782

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.